Announce Date | 05/07/2025 |
EPS Normalized Actual | $0.14 (Beat by $0.02) |
EPS GAAP Actual | $0.14 (Beat by $0.02) |
Revenue Actual | $0.6626B |
Revenue Surprise | Beat by $662.6M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.35124 |
EPS GAAP Estimate | $0.35124 |
Revenue Estimate | $0.765454325B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2027 | 1.09 | 13.9 | 1.08229 | 1.09621 | 1 |
Sep 2026 | 0.92851 | 16.32 | 0.91652 | 0.94421 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.03 | -0.119621 | 0.6626B | -1.55% | -30.59M |
FQ4 2024 (Dec 2024) | -0.11 | -0.151514 | 0.5992B | -4.59% | -31.85M |
FQ3 2024 (Sep 2024) | 0.11 | 0.11 | 0.7287B | -2.06% | 728.7M |
FQ1 2017 (Mar 2017) | -0.39 | -0.39 | 0.5191B | 100% | 519.1M |
FQ2 2017 (Jun 2017) | 0.2 | 0.2 | 0.62749B | 100% | 627.49M |
FQ3 2017 (Sep 2017) | 0.0055 | 0.0055 | 0.566988B | 100% | 566.99M |
FQ2 2024 (Jun 2024) | 0.15 | 0.15 | 0.7388B | -3.68% | 738.8M |
FQ1 2024 (Mar 2024) | 0.17 | 0.17 | 0.6729B | 3.34% | 672.9M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.35124
Consensus Revenue Estimates
0.765454325B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | 0.44796 | -- | 0.43993 | 0.45394 | 5 |
FQ1 2027 (Mar 2027) | 0.20119 | -- | 0.19758 | 0.20388 | 3 |
FQ4 2026 (Oct 2026) | 0.36005 | -- | 0.35319 | 0.37105 | 1 |
FQ3 2026 (Jul 2026) | 0.3829 | -- | 0.3756 | 0.3946 | 1 |
FQ2 2026 (Jun 2026) | 0.36493 | -- | 0.35885 | 0.36992 | 1 |
FQ1 2026 (Mar 2026) | 0.10786 | 127.81 | 0.10606 | 0.10933 | 1 |
FQ4 2025 (Oct 2025) | 0.32968 | 133.37 | 0.3234 | 0.33976 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | 0.83B | -- | 0.82B | 0.84B | 6 |
FQ1 2027 (Mar 2027) | 0.68B | -- | 0.67B | 0.69B | 4 |
FQ4 2026 (Oct 2026) | 0.77B | -- | 0.76B | 0.79B | 2 |
FQ3 2026 (Jul 2026) | 0.78B | -- | 0.77B | 0.8B | 2 |
FQ2 2026 (Jun 2026) | 0.81B | -- | 0.8B | 0.82B | 2 |
FQ1 2026 (Mar 2026) | 0.71B | 6.29 | 0.7B | 0.71B | 2 |
FQ4 2025 (Oct 2025) | 0.76B | 20.91 | 0.75B | 0.78B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.089621 | -0.03 | -0.119621 | 398.74% |
FQ4 2024 (Dec 2024) | 0.041514 | -0.11 | -0.151514 | 137.74% |
FQ3 2024 (Sep 2024) | 0.11 | 0.11 | 100% | |
FQ1 2017 (Mar 2017) | -0.39 | -0.39 | 100% | |
FQ2 2017 (Jun 2017) | 0.2 | 0.2 | 100% | |
FQ3 2017 (Sep 2017) | 0.0055 | 0.0055 | 100% | |
FQ2 2024 (Jun 2024) | 0.15 | 0.15 | 100% | |
FQ1 2024 (Mar 2024) | 0.17 | 0.17 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.69B | $0.66B | $-30.59M | -4.62% |
FQ4 2024 (Dec 2024) | $0.63B | $0.6B | $-31.85M | -5.32% |
FQ3 2024 (Sep 2024) | $0B | $0.73B | $728.7M | 100% |
FQ1 2017 (Mar 2017) | $0B | $0.52B | $519.1M | 100% |
FQ2 2017 (Jun 2017) | $0B | $0.63B | $627.49M | 100% |
FQ3 2017 (Sep 2017) | $0B | $0.57B | $566.99M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.74B | $738.8M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.67B | $672.9M | 100% |